Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-03-06

Clinical Trial Update: Control-IQ Technology in Individuals With Type 2 Diabetes [NA]

View source ↗

Summary

A completed clinical trial update on Control-IQ Technology for Type 2 Diabetes treated with insulin.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Control-IQ Technology

Snippet

Sponsor: Tandem Diabetes Care, Inc. | Conditions: Type 2 Diabetes Treated With Insulin | NA | Status: COMPLETED | Results posted: 2024-03-06